Kura Oncology gains after CEO's second stock purchase this month
+9.60% to $13.59 from $12.40
What moved KURA
- Kura Oncology CEO Troy Wilson purchased 100,000 shares for about $1.24 million, a regulatory filing showed.
- It was Wilson’s second 100,000-share purchase this month, after buying shares on August 17 at $11.12 each.
- Shares gained roughly 10-11% following the disclosure.
Sources: Investing.com · GuruFocus · CNBC